As the project moves ahead, the hospital group is also seeking to cut staffing costs, trimming its executive numbers from nine to six and incentivizing 34 other employees to take early retirement.
Despite the need to raise more money, the project remains on time, CEO Todd Forkel told the newspaper.
The seven-story building, which is due to be completed in 2024, will not likely see its first patients until early 2025, he said.
The $380 million project will have 226 beds, a neonatal intensive care unit and a trauma operating room, as well as other facilities.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
